Does ROZANOLIXIZUMAB Cause Therapeutic product effect incomplete? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Therapeutic product effect incomplete have been filed in association with ROZANOLIXIZUMAB (RYSTIGGO). This represents 4.3% of all adverse event reports for ROZANOLIXIZUMAB.
13
Reports of Therapeutic product effect incomplete with ROZANOLIXIZUMAB
4.3%
of all ROZANOLIXIZUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From ROZANOLIXIZUMAB?
Of the 13 reports, 2 (15.4%) required hospitalization, and 1 (7.7%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROZANOLIXIZUMAB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does ROZANOLIXIZUMAB Cause?
Myasthenia gravis (158)
Headache (64)
Drug ineffective (54)
Diarrhoea (41)
Asthenia (36)
Fatigue (34)
Dyspnoea (29)
Nausea (25)
Fall (22)
Therapeutic response shortened (22)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which ROZANOLIXIZUMAB Alternatives Have Lower Therapeutic product effect incomplete Risk?
ROZANOLIXIZUMAB vs ROZANOLIXIZUMAB-NOLI
ROZANOLIXIZUMAB vs RUBIDIUM RB-82
ROZANOLIXIZUMAB vs RUCAPARIB
ROZANOLIXIZUMAB vs RUCAPARIB CAMSYLATE
ROZANOLIXIZUMAB vs RUFINAMIDE